MedTrace Logo

Long-term Evaluation of the Linox Family ICD Leads Registry (GALAXY)

NCT00836589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1997

Last updated 2019-02-15

Study results available
· View outcomes & findings →

Summary

The objective of this study is to confirm the long-term safety and reliability of the Linox Lead System as used with BIOTRONIK ICDs. The GALAXY registry will provide data to fully characterize ICD lead failures, from implant through 5 years, including those failures contributing to patients losing pacing or defibrillation therapy.

Conditions

  • Patients Indicated for an ICD

Interventions

DEVICE

ICD Therapy - ICD Lead Registry

Collecting long-term safety and efficacy data on a family of market-released ICD leads.

Sponsors & Collaborators

  • Biotronik, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00836589 on ClinicalTrials.gov